XML 54 R38.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Equity and Stock Compensation Plans (Tables)
12 Months Ended
Oct. 01, 2017
Stockholders' Equity Note [Abstract]  
Schedule of the stock-based compensation and related income tax benefits
The stock-based compensation and related income tax benefits were as follows:
 
Fiscal Year Ended
 
October 1,
2017
 
October 2,
2016
 
September 27,
2015
 
(in thousands)
Total stock-based compensation
$
13,450

 
$
12,964

 
$
10,926

Income tax benefit related to stock-based compensation
(4,715
)
 
(4,656
)
 
(3,811
)
Stock-based compensation, net of tax benefit
$
8,735

 
$
8,308

 
$
7,115

Schedule of stock option activity
Stock option activity for the fiscal year ended October 1, 2017 was as follows:
 
Number of
Options
(in thousands)
 
Weighted-
Average
Exercise Price
per Share
 
Weighted-
Average
Remaining
Contractual
Term
(in years)
 
Aggregate
Intrinsic Value
(in thousands)
Outstanding on October 2, 2016
2,367

 
$
24.88

 
 
 
 

Granted
183

 
40.67

 
 
 
 

Exercised
(791
)
 
44.19

 
 
 
 

Forfeited
(6
)
 
17.72

 
 
 
 

Outstanding at October 1, 2017
1,753

 
27.18

 
4.59
 
$
33,963

 
 
 
 
 
 
 
 
Vested or expected to vest at October 1, 2017
1,696

 
27.31

 
4.50
 
32,640

Exercisable on October 1, 2017
1,242

 
25.10

 
3.43
 
26,636

Schedule of assumptions used in the calculation of the fair value of stock options using the Black-Scholes option pricing model
The fair value of our stock options was estimated on the date of grant using the Black-Scholes option pricing model. The following assumptions were used in the calculation:
 
Fiscal Year Ended
 
October 1,
2017
 
October 2,
2016
 
September 27,
2015
Dividend yield
1.0%
 
1.2%
 
1.0%
Expected stock price volatility
36.1% - 38.8%
 
36.1% - 38.8%
 
36.2% - 38.8%
Risk-free rate of return, annual
1.7% - 1.9%
 
1.6% - 1.8%
 
1.5% - 1.7%
Schedule of restricted stock activity
Restricted stock activity for the fiscal year ended October 1, 2017 was as follows:
 
Number of
Shares
(in thousands)
 
Weighted-
Average Grant
Date Fair
Value
Nonvested balance at October 2, 2016
35

 
$
28.58

Granted
14

 
28.58

Vested
(49
)
 
28.58

Forfeited

 

Nonvested balance at October 1, 2017

 

 
 
 
 
Vested or expected to vest at October 1, 2017

 

Schedule of performance-based awards
PSU activity for the fiscal year ended October 1, 2017 was as follows:
 
Number of
Shares
(in thousands)
 
Weighted-
Average Grant
Date Fair
Value
Nonvested balance at October 2, 2016
277

 
$
31.65

Granted
99

 
48.36

Nonvested balance at October 1, 2017
376

 
36.05

Schedule of RSU activity
RSU activity for the fiscal year ended October 1, 2017 was as follows:
 
Number of
Shares
(in thousands)
 
Weighted-
Average Grant
Date Fair
Value
Nonvested balance at October 2, 2016
499

 
$
27.16

Granted
226

 
41.00

Vested
(186
)
 
26.98

Forfeited
(28
)
 
30.15

Nonvested balance at October 1, 2017
511

 
33.19

Summary of shares purchased, weighted-average purchase price, cash received, and the aggregate intrinsic value for shares purchased under the ESPP
The following table summarizes shares purchased, weighted-average purchase price, cash received and the aggregate intrinsic value for shares purchased under the ESPP:
 
Fiscal Year Ended
 
October 1,
2017
 
October 2,
2016
 
September 27,
2015
 
(in thousands, except for purchase price)
Shares purchased
190

 
209

 
243

Weighted-average purchase price
$
26.02

 
$
22.54

 
$
21.44

Cash received from exercise of purchase rights
$
4,940

 
$
4,707

 
$
5,204

Aggregate intrinsic value
$

 
$
710

 
$
1,277

Schedule of the assumptions used in the Black-Scholes option pricing model in estimating the grant date fair value of each award granted under the ESPP
The grant date fair value of each award granted under the ESPP was estimated using the Black-Scholes option pricing model with the following assumptions:
 
Fiscal Year Ended
 
October 1,
2017
 
October 2,
2016
 
September 27,
2015
Dividend yield
1.0%
 
1.3%
 
1.1%
Expected stock price volatility
22.4%
 
23.7%
 
23.7%
Risk-free rate of return, annual
0.9%
 
0.2%
 
0.2%
Expected life (in years)
1
 
1
 
1